AAAAAA
Results:
1-19
|
Results: 19
Authors:
RAYMOND E
CHANEY SG
TAAMMA A
CVITKOVIC E
Citation: E. Raymond et al., OXALIPLATIN - A REVIEW OF PRECLINICAL AND CLINICAL-STUDIES, Annals of oncology, 9(10), 1998, pp. 1053-1071
Authors:
RAYMOND E
FAIVRE S
WOYNAROWSKI JM
CHANEY SG
Citation: E. Raymond et al., OXALIPLATIN - MECHANISM OF ACTION AND ANTINEOPLASTIC ACTIVITY, Seminars in oncology, 25(2), 1998, pp. 4-12
Authors:
VAISMAN A
VARCHENKO M
UMAR A
KUNKEL TA
RISINGER JI
BARRETT JC
HAMILTON TC
CHANEY SG
Citation: A. Vaisman et al., THE ROLE OF HMLH1, HMSH3, AND HMSH6 DEFECTS IN CISPLATIN AND OXALIPLATIN RESISTANCE - CORRELATION WITH REPLICATIVE BYPASS OF PLATINUM-DNA ADDUCTS, Cancer research, 58(16), 1998, pp. 3579-3585
Authors:
CHANEY SG
VAISMAN A
VARCHENKO M
Citation: Sg. Chaney et al., DECREASED INHIBITION OF DNA-REPLICATION BY PLATINUM ADDUCTS IN MISMATCH REPAIR DEFECTIVE CELL-LINES, The FASEB journal, 11(9), 1997, pp. 1949-1949
Authors:
DELMASTRO DA
LI JB
VAISMAN A
SOLLE M
CHANEY SG
Citation: Da. Delmastro et al., DNA-DAMAGE INDUCIBLE-GENE EXPRESSION FOLLOWING PLATINUM TREATMENT IN HUMAN OVARIAN-CARCINOMA CELL-LINES, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 245-253
Authors:
VAISMAN A
VARCHENKO M
SAID I
CHANEY SG
Citation: A. Vaisman et al., CELL-CYCLE CHANGES ASSOCIATED WITH FORMATION OF PT-DNA ADDUCTS IN HUMAN OVARIAN-CARCINOMA CELLS WITH DIFFERENT CISPLATIN SENSITIVITY, Cytometry, 27(1), 1997, pp. 54-64
Authors:
CHANEY SG
SANCAR A
Citation: Sg. Chaney et A. Sancar, DNA-REPAIR - ENZYMATIC MECHANISMS AND RELEVANCE TO DRUG RESPONSE, Journal of the National Cancer Institute, 88(19), 1996, pp. 1346-1360
Authors:
VAISMAN A
KEENEY S
NICHOLS AF
LINN S
CHANEY SG
Citation: A. Vaisman et al., CISPLATIN-INDUCED ALTERATIONS IN THE EXPRESSION OF THE MESSENGER-RNASFOR UV-DAMAGE RECOGNITION PROTEIN, Oncology research, 8(1), 1996, pp. 7-12
Authors:
PETERSEN LN
MAMENTA EL
STEVNSNER T
CHANEY SG
BOHR VA
Citation: Ln. Petersen et al., INCREASED GENE-SPECIFIC REPAIR OF CISPLATIN-INDUCED INTERSTRAND CROSS-LINKS IN CISPLATIN-RESISTANT CELL-LINES, AND STUDIES ON CARRIER LIGAND SPECIFICITY, Carcinogenesis, 17(12), 1996, pp. 2597-2602
Authors:
CHANEY SG
Citation: Sg. Chaney, THE CHEMISTRY AND BIOLOGY OF PLATINUM COMPLEXES WITH THE 1,2-DIAMINOCYCLOHEXANE CARRIER LIGAND (REVIEW), International journal of oncology, 6(6), 1995, pp. 1291-1305
Authors:
SAKATA M
CHANEY SG
SPRIGGS DR
Citation: M. Sakata et al., POSSIBLE CORRELATION BETWEEN ORMAPLATIN BIOTRANSFORMATIONS AND NEUROTOXICITY, Oncology research, 7(2), 1995, pp. 67-71
Authors:
THOMSPON DC
WYRICK SD
HOLBROOK DJ
CHANEY SG
Citation: Dc. Thomspon et al., EFFECTS OF ANESTHETICS ON ORMAPLATIN BIOTRANSFORMATIONS IN THE FISCHER-344 RAT, Cancer investigation, 13(5), 1995, pp. 555-557
Authors:
THOMPSON DC
VAISMAN A
SAKATA MK
WYRICK SD
HOLBROOK DJ
CHANEY SG
Citation: Dc. Thompson et al., ORGAN-SPECIFIC BIOTRANSFORMATION OF ORMAPLATIN IN THE FISCHER-344 RAT, Cancer chemotherapy and pharmacology, 36(5), 1995, pp. 439-447
Authors:
THOMPSON DC
WYRICK SD
HOLBROOK DJ
CHANEY SG
Citation: Dc. Thompson et al., EFFECT OF THE CHEMOPROTECTIVE AGENT WR-2721 ON DISPOSITION AND BIOTRANSFORMATIONS OF ORMAPLATIN IN THE FISCHER-344 RAT BEARING A FIBROSARCOMA, Cancer research, 55(13), 1995, pp. 2837-2846
Authors:
VAISMAN A
CHANEY SG
Citation: A. Vaisman et Sg. Chaney, INDUCTION OF UV-DAMAGE RECOGNITION PROTEIN BY CISPLATIN TREATMENT, Biochemistry, 34(1), 1995, pp. 105-114
Authors:
THOMPSON DC
WYRICK SD
HOLBROOK DJ
CHANEY SG
Citation: Dc. Thompson et al., HPLC AND P-31 NMR CHARACTERIZATION OF THE REACTION BETWEEN ANTITUMOR PLATINUM AGENTS AND THE PHOSPHOROTHIOATE CHEMOPROTECTIVE AGENT S-2-(3-AMINOPROPYLAMINO)ETHYLPHOSPHOROTHIOIC ACID (WR-2721), Biochemical pharmacology, 50(9), 1995, pp. 1413-1419
Authors:
SHAMKHANI H
ANDERSON LM
HENDERSON CE
MOSKAL TJ
RUNOWICZ CD
DOVE LF
JONES AB
CHANEY SG
RICE JM
POIRIER MC
Citation: H. Shamkhani et al., DNA-ADDUCTS IN HUMAN AND PATAS MONKEY MATERNAL AND FETAL TISSUES INDUCED BY PLATINUM DRUG CHEMOTHERAPY, Reproductive toxicology, 8(3), 1994, pp. 207-216
Authors:
PETROS WP
CHANEY SG
SMITH DC
FANGMEIER J
SAKATA M
BROWN TD
TRUMP DL
Citation: Wp. Petros et al., PHARMACOKINETIC AND BIOTRANSFORMATION STUDIES OF ORMAPLATIN IN CONJUNCTION WITH A PHASE-I CLINICAL-TRIAL, Cancer chemotherapy and pharmacology, 33(4), 1994, pp. 347-354
Authors:
MAMENTA EL
POMA EE
KAUFMANN WK
DELMASTRO DA
GRADY HL
CHANEY SG
Citation: El. Mamenta et al., ENHANCED REPLICATIVE BYPASS OF PLATINUM-DNA ADDUCTS IN CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINES, Cancer research, 54(13), 1994, pp. 3500-3505
Risultati:
1-19
|